HSBC Holdings plc

HSBC · Financial Services · $100.95
✦ AI ANALYSIS — not investment advice
BUY Medium conviction 6-12 months
$108.51target
↗ 7.5% above the current $100.95

HSBC is still being valued like a mature bank at 14.29x earnings even as FY26 earnings power is being lifted by a Banking NII guide of at least $46B, strict ~1% cost growth, and resumed capital returns.

Confidence medium
◆Investment thesis

HSBC is being priced like a steady bank when the current setup is better than steady. The market sees a diversified global bank on 14.29x earnings, roughly in line with the 14.3x peer average, but the underlying engine is improving in a more favorable way than a flat peer comparison suggests. Management has already raised FY26 Banking NII guidance to at least $46B, revenue in the latest quarter grew 7% YoY to $19B, and PBT reached $10.3B, up 13% YoY. That is not the profile of an earnings stream rolling over.

The first thing the case depends on is that rate support and balance-sheet growth continue to coexist. Q2 showed deposits up $46B and loans up $20B, which matters because it indicates HSBC is not only harvesting old asset yields. The caveat is quality, since management admitted about half of CIB deposit growth was large and short term. Even so, the raised NII guide suggests management sees enough durability in volumes and mix to offset that churn.

The second thing is operating discipline. HSBC is guiding to only around 1% cost growth in FY26 versus FY25 while also raising simplification savings to $2B by end-2026. That is where the upside sits. If a bank with 53.7% FY2025 operating margin can hold expenses nearly flat while wealth fees grow and rate income remains firm, earnings should outpace revenue. AI does not transform the story, but it can reinforce it through compliance, servicing, and process automation, which is valuable for a global bank dealing with large operating complexity.

The third thing is capital return. With CET1 at 14.1%, a resumed up to $1B buyback, and a 50% dividend payout ratio, shareholders are getting paid while waiting. The main reason conviction is not higher is valuation versus setup. Shares are only 6.5% below the 52-week high, so the stock needs another clean quarter to work. Still, at this price the market is not paying a premium for a bank that is simplifying, raising guidance, and producing broad-based returns above 17% annualized RoTE across all four businesses.

⋔Scenarios · 6-12 months
$82bear · 25%
$109base · 50%
$125bull · 25%
Bull

Wealth fees and transaction banking stay strong, cost saves exceed plan, and investors pay closer to the quality-adjusted value of $125.6.

Base

HSBC delivers on at least $46B Banking NII, keeps costs near 1% growth, and maintains buybacks and dividends with stable credit.

Bear

NII rolls over, ECL runs above the guided 45 bps, and near-peak positioning unwinds as the stock loses its premium near the top of the range.

⊚Signal check
AIBUY
QuantHOLD
Analysts—
contrarian

No analyst coverage available to cross-check.

◑Quality & risk
69Quality
25Risk
Quality factors
Profitability86
Shareholder83
Financial health82
Valuation81
Sentiment74
Growth65
Innovation50
Cash flow10
Risk drivers · Low
Execution36%
Market26%
Valuation20%
Financial18%
patiencesentiment
You have power over your mind — not outside events. Realize this, and you will find strength.
— Marcus Aurelius
→Forward outlook

Forward earnings power is better than trailing numbers suggest because management has already raised FY26 Banking NII to at least $46B, is holding cost growth to around 1%, and is layering in $2B of simplification savings by end-2026. Against trailing EPS of $6.05 and a 14.29x trailing P/E, the stock does not look expensive if NII, wealth fees, and transaction banking keep compounding, and forward P/E should drift below trailing on that path. The moat looks slightly stronger today than three years ago because HSBC is concentrating around Asia wealth, transaction banking, and core corporate flows rather than subscale retail assets, but regulation and capital demands will keep upside capped versus pure fee franchises. AI is more of an efficiency tool than a revenue unlock here, but for a bank guiding ~1% cost growth, even modest gains in servicing, compliance, and fraud control matter if they help protect margins rather than disrupt the franchise.

⚡Key drivers
Bull case
  • FY2025 revenue grew 7.1% to $134.1B and EPS grew 6.0% to $6.05, while profitability stayed strong with a 53.7% operating margin and 33.5% net margin.
  • Q2 operating momentum improved materially: PBT $10.3B, up 13% YoY, revenue $19B, up 7% YoY, and EBITDA margin 34.8%, up 500 bps vs Q1 and 1,130 bps YoY.
  • Balance-sheet growth is real, not just rate mix: deposits rose $46B and loans rose $20B in Q2, while wealth fee income rose 21% and net new money hit $25B.
  • Valuation is still reasonable for that profile at 14.29x P/E, essentially in line with the 14.3x peer average, despite higher capital return and a 69/100 quality score with 25/100 risk score (Low).
Bear case
  • The stock is no longer early. At $100.95, shares are 10.3% above the 200-day average and only 6.5% below the 52-week and 5-year high of $107.92, which limits room for disappointment.
  • Credit costs are moving above the older normal range. FY26 ECL is guided at around 45 bps, versus the 30 to 40 bps range management outlined back in the 2024 Q3 period, and Q2 ECL was $1.1B, including $0.2B tied to Hong Kong CRE Stage 3 charges.
  • Funding quality has a caveat: management said about half of CIB deposit growth was large and short term, so not all of the $46B deposit increase should be treated as durable.
  • Cash flow optics are weak in the supplied data, with FCF $0.0B, capex $0.0B, buybacks $0.0B, and dividends $0.0B, which reduces visibility if reported accounting momentum weakens.
⌗Key metrics
MetricValueContext
Current price$100.95Reference price for the engine target and scenario analysis
Quant price target$108.51Ground-truth target, 7.5% upside, Medium confidence
FY2025 revenue$134.1B+7.1% YoY, healthy growth for a large diversified bank
FY2025 EPS$6.05+6.0% YoY, supports the current earnings base
FY2025 operating margin53.7%Up sharply from 22.5% prior FY
ValuationP/E 14.29 | P/S 2.55 | P/B 1.74P/E is in line with peer average 14.3x, P/S above peer 2.1x
Q2 FY2026 operating updateRevenue $19B | PBT $10.3B | EBITDA $11.88BRevenue +7% YoY, PBT +13% YoY, EBITDA margin 34.8%
FY26 management guidanceBanking NII at least $46B | ECL around 45 bps | Cost growth around 1%Core forward earnings framework after the Q2 raise
Capital strengthCET1 14.1% | Debt/Equity 0.68 | Debt/EBITDA 3.82Solid capital supports distributions despite normal bank leverage optics
Capital return50% dividend payout ratio | Up to $1B buybackBuybacks resumed after a three-quarter pause
Quality and riskQuality 69/100 | Risk 25/100 (Low)Profitability 86, Financial Health 82, Cash Flow Quality only 10
Price action52-week range $65.67-$107.92Stock is -6.5% from high and 10.3% above the 200-day average of $91.53
◎How the $108.51 target is built
P/E Multiple · 28%$117.72
PEG (growth-adjusted) · 20%$74.55
P/S Multiple · 20%$99.09
Quality-adjusted · 20%$125.60
DCF · 7% (faded)$146.57
Medium confidence · earnings growth blend blend
⚑Risk & catalyst
Primary risk

The biggest risk is that rate-driven earnings have peaked, because HSBC trades at 14.29x earnings near its highs while FY26 still assumes Banking NII of at least $46B and only around 45 bps of credit losses.

Next catalyst

The next catalyst is Q3 earnings on October 27, 2026, especially whether management sustains the at least $46B Banking NII guide and keeps cost growth near 1%.

⇄Positioning & flows
Short interest0.2% of float · 3.8d to cover · +4.4%
Options GEXnegative regime · flip $103
put wall $99call wall $105

Ownership is unusually diffuse in the supplied data, with the top 3 institutions holding 1.5% and insider ownership at 0.0%, so the stock does not look tightly controlled by a concentrated holder base. Short interest is very low at 0.16% of shares, or 5.4M shares and 3.8 days to cover, which limits squeeze potential but also signals little outright bearish conviction. Options positioning is more relevant near-term: the negative gamma regime with a zero-gamma level at $102.63, just 1.62% above spot, suggests trading can stay choppy around earnings rather than trend smoothly upward.

▦Segments
Geography, Asia-led franchise

Asia is the clearest growth engine, with net new money of $25B in Q2 led by Asia and wealth fee income up 21%.

Wealth

Fee stream remains a standout, following +32% YoY wealth growth in the 2024 Q3 period and +21% wealth fee growth in 2026 Q2.

Transaction banking and CIB

Supported Q2 revenue and deposit growth, but management flagged that about half of CIB deposit growth was large and short term.

All four businesses4 operating businesses

Management said all four businesses delivered more than 17% annualized RoTE in Q2, showing broad-based profitability.

▤Latest earnings call · Q2 2026

HSBC posted strong Q2 momentum and raised Banking NII guidance.

Call sentiment 78/100
“Management

Execution looks credible, with some noise but more hits than misses on what management laid out in the 2024 Q3 period. Back then, management held FY24 Banking NII around $43B, targeted mid-teens ROTE for 2024 and 2025, and said restructuring benefits would exceed costs with a short payback; since then, HSBC has moved to a cleaner four-business structure, completed 15 exits since 2025, resumed buybacks, and in 2026 Q2 raised Banking NII guidance to at least $46B while increasing savings to $2B on the same $1.8B restructuring envelope. Performance has improved versus that earlier base, with Q3 2024 PBT of $8.5B and $17B revenue rising to Q2 2026 PBT of $10.3B and $19B revenue, while EBITDA margin improved from 24.6% in the 2024 Q3 period to 34.8% in 2026 Q2. The miss is credit normalization, because ECL expectations widened from 30 to 40 bps back then to around 45 bps now, and recent beat/miss history is mixed, +20.4%, -8.3%, then +0.4%, so management deserves moderate, not full, benefit of the doubt.

NII guidance
We are upgrading our full year banking NII guidance to at least USD 46 billion.
— Manveen Kaur, CFO · Q2 2026 earnings call
Cost saves
We are today revising upwards our total target savings to USD 2 billion.
— Georges Elhedery, CEO · Q2 2026 earnings call
Quarter performance
Momentum accelerated into the second quarter. We grew revenues by 7% to USD 19 billion.
— Georges Elhedery, CEO · Q2 2026 earnings call
Cost outlook
We are on track to achieve our target of around 1% cost growth in 2026 compared to 2025 on a target basis.
— Manveen Kaur, CFO · Q2 2026 earnings call
Capital priorities
The second priority use of our capital is to support business organic growth. This is how we can generate the highest value for our shareholders when we do it, of course, within risk appetite and at the right returns.
— Georges Elhedery, CEO · Q2 2026 earnings call
◈Moat & edge

HSBC's edge is the combination of global corporate banking connectivity and a strong Asia wealth and deposits franchise. That is hard to replicate because clients use the network for payments, trade, deposits, and investment products together, and the funding base helps protect NII and returns. The moat is durable but not absolute, because regulation keeps capital high and some rate-related earnings remain cyclical, so durability depends on growing fee-heavy wealth and transaction banking faster than pure spread income over the next 3 to 5 years.

⊞Capital allocation

Capital allocation is disciplined right now. HSBC resumed buybacks with up to $1B after a three-quarter pause and is targeting a 50% dividend payout ratio for FY26, while still prioritizing organic growth where returns clear hurdle rates. The other notable decision is simplification: 15 exits since 2025 and a raised $2B savings target on the same $1.8B restructuring envelope suggest management is shrinking lower-return complexity rather than chasing M&A.

∎The bottom line

HSBC rates a BUY with Medium conviction. The stock is not a bargain-basement bank trade, but the current earnings path looks better than the market is discounting, with a raised $46B+ NII guide, tight cost control, solid capital, and resumed buybacks. The main limitation is setup: shares are already near highs, so execution has to stay clean. A downgrade to HOLD would follow if October results show NII softening, cost growth drifting above 1%, or ECL clearly moving above the guided 45 bps. Until then, the forward earnings path still supports owning the shares.

≣ Full research note tap to expand

Executive Summary

BUY, Medium conviction. Rated BUY, Medium conviction. HSBC is not cheap on every metric, but the setup still leans favorable because earnings power is improving faster than the market is crediting, with Q2 PBT up 13% YoY, revenue up 7% YoY, and management raising NII and cost-save targets at the same time. At $100.95, only 6.5% below the 52-week high, this is not a deep-value trade, but the business is carrying enough momentum and capital flexibility to support a move toward the engine base case of $108.51 and potentially higher if execution holds through October earnings.

Investment Thesis

HSBC is being priced like a steady bank when the current setup is better than steady. The market sees a diversified global bank on 14.29x earnings, roughly in line with the 14.3x peer average, but the underlying engine is improving in a more favorable way than a flat peer comparison suggests. Management has already raised FY26 Banking NII guidance to at least $46B, revenue in the latest quarter grew 7% YoY to $19B, and PBT reached $10.3B, up 13% YoY. That is not the profile of an earnings stream rolling over.

The first thing the case depends on is that rate support and balance-sheet growth continue to coexist. Q2 showed deposits up $46B and loans up $20B, which matters because it indicates HSBC is not only harvesting old asset yields. The caveat is quality, since management admitted about half of CIB deposit growth was large and short term. Even so, the raised NII guide suggests management sees enough durability in volumes and mix to offset that churn.

The second thing is operating discipline. HSBC is guiding to only around 1% cost growth in FY26 versus FY25 while also raising simplification savings to $2B by end-2026. That is where the upside sits. If a bank with 53.7% FY2025 operating margin can hold expenses nearly flat while wealth fees grow and rate income remains firm, earnings should outpace revenue. AI does not transform the story, but it can reinforce it through compliance, servicing, and process automation, which is valuable for a global bank dealing with large operating complexity.

The third thing is capital return. With CET1 at 14.1%, a resumed up to $1B buyback, and a 50% dividend payout ratio, shareholders are getting paid while waiting. The main reason conviction is not higher is valuation versus setup. Shares are only 6.5% below the 52-week high, so the stock needs another clean quarter to work. Still, at this price the market is not paying a premium for a bank that is simplifying, raising guidance, and producing broad-based returns above 17% annualized RoTE across all four businesses.

Key Metrics

MetricValueContext
Current price$100.95Reference price for the engine target and scenario analysis
Quant price target$108.51Ground-truth target, 7.5% upside, Medium confidence
FY2025 revenue$134.1B+7.1% YoY, healthy growth for a large diversified bank
FY2025 EPS$6.05+6.0% YoY, supports the current earnings base
FY2025 operating margin53.7%Up sharply from 22.5% prior FY
ValuationP/E 14.29P/S 2.55P/B 1.74P/E is in line with peer average 14.3x, P/S above peer 2.1x
Q2 FY2026 operating updateRevenue $19BPBT $10.3BEBITDA $11.88BRevenue +7% YoY, PBT +13% YoY, EBITDA margin 34.8%
FY26 management guidanceBanking NII at least $46BECL around 45 bpsCost growth around 1%Core forward earnings framework after the Q2 raise
Capital strengthCET1 14.1%Debt/Equity 0.68Debt/EBITDA 3.82Solid capital supports distributions despite normal bank leverage optics
Capital return50% dividend payout ratioUp to $1B buybackBuybacks resumed after a three-quarter pause
Quality and riskQuality 69/100Risk 25/100 (Low)Profitability 86, Financial Health 82, Cash Flow Quality only 10
Price action52-week range $65.67-$107.92Stock is -6.5% from high and 10.3% above the 200-day average of $91.53

Financial Strength

HSBC's balance sheet reads as solid for a global bank. CET1 at 14.1% gives room for both organic growth and resumed buybacks, and the debt metrics, 0.68 debt/equity and 3.82 debt/EBITDA, are manageable in the context of a deposit-funded institution. Profitability is the stronger part of the story, with 53.7% FY2025 operating margin and 33.5% net margin, plus a Q2 EBITDA margin that improved to 34.8%. The weak spot is cash flow presentation, where the supplied data shows FCF at $0.0B and a Cash Flow Quality score of 10, so the balance-sheet comfort rests more on capital ratios and earnings capacity than on clean reported free-cash-flow conversion.

Competitive Position

HSBC's edge is the combination of global corporate banking connectivity and a strong Asia wealth and deposits franchise. That is hard to replicate because clients use the network for payments, trade, deposits, and investment products together, and the funding base helps protect NII and returns. The moat is durable but not absolute, because regulation keeps capital high and some rate-related earnings remain cyclical, so durability depends on growing fee-heavy wealth and transaction banking faster than pure spread income over the next 3 to 5 years.

Management & Guidance

Management guidance has improved, not just been maintained. In the 2026 Q2 call, the CFO said, "We are upgrading our full year banking NII guidance to at least USD 46 billion." The same call held cost discipline with around 1% cost growth for FY26, while the CEO said, "We are today revising upwards our total target savings to USD 2 billion." Guidance credibility is decent because the bank is raising NII on the back of visible drivers, including $46B deposit growth, $20B loan growth, and 21% wealth fee growth, but it is not pristine because quarterly earnings execution has been mixed, with one notable -8.3% EPS miss in May 2026 and because ECL is now guided at a higher 45 bps than the older normal range.

Segment Analysis

  • Geography, Asia-led franchise (N/A in supplied data): Asia is the clearest growth engine, with net new money of $25B in Q2 led by Asia and wealth fee income up 21%.
  • Wealth (N/A in supplied data): Fee stream remains a standout, following +32% YoY wealth growth in the 2024 Q3 period and +21% wealth fee growth in 2026 Q2.
  • Transaction banking and CIB (N/A in supplied data): Supported Q2 revenue and deposit growth, but management flagged that about half of CIB deposit growth was large and short term.
  • All four businesses (4 operating businesses): Management said all four businesses delivered more than 17% annualized RoTE in Q2, showing broad-based profitability.

Capital Allocation

Capital allocation is disciplined right now. HSBC resumed buybacks with up to $1B after a three-quarter pause and is targeting a 50% dividend payout ratio for FY26, while still prioritizing organic growth where returns clear hurdle rates. The other notable decision is simplification: 15 exits since 2025 and a raised $2B savings target on the same $1.8B restructuring envelope suggest management is shrinking lower-return complexity rather than chasing M&A.

Management Execution & Track Record

Execution looks credible, with some noise but more hits than misses on what management laid out in the 2024 Q3 period. Back then, management held FY24 Banking NII around $43B, targeted mid-teens ROTE for 2024 and 2025, and said restructuring benefits would exceed costs with a short payback; since then, HSBC has moved to a cleaner four-business structure, completed 15 exits since 2025, resumed buybacks, and in 2026 Q2 raised Banking NII guidance to at least $46B while increasing savings to $2B on the same $1.8B restructuring envelope. Performance has improved versus that earlier base, with Q3 2024 PBT of $8.5B and $17B revenue rising to Q2 2026 PBT of $10.3B and $19B revenue, while EBITDA margin improved from 24.6% in the 2024 Q3 period to 34.8% in 2026 Q2. The miss is credit normalization, because ECL expectations widened from 30 to 40 bps back then to around 45 bps now, and recent beat/miss history is mixed, +20.4%, -8.3%, then +0.4%, so management deserves moderate, not full, benefit of the doubt.

Positioning & Flows

Ownership is unusually diffuse in the supplied data, with the top 3 institutions holding 1.5% and insider ownership at 0.0%, so the stock does not look tightly controlled by a concentrated holder base. Short interest is very low at 0.16% of shares, or 5.4M shares and 3.8 days to cover, which limits squeeze potential but also signals little outright bearish conviction. Options positioning is more relevant near-term: the negative gamma regime with a zero-gamma level at $102.63, just 1.62% above spot, suggests trading can stay choppy around earnings rather than trend smoothly upward.

Bull Case

  • FY2025 revenue grew 7.1% to $134.1B and EPS grew 6.0% to $6.05, while profitability stayed strong with a 53.7% operating margin and 33.5% net margin.
  • Q2 operating momentum improved materially: PBT $10.3B, up 13% YoY, revenue $19B, up 7% YoY, and EBITDA margin 34.8%, up 500 bps vs Q1 and 1,130 bps YoY.
  • Balance-sheet growth is real, not just rate mix: deposits rose $46B and loans rose $20B in Q2, while wealth fee income rose 21% and net new money hit $25B.
  • Valuation is still reasonable for that profile at 14.29x P/E, essentially in line with the 14.3x peer average, despite higher capital return and a 69/100 quality score with 25/100 risk score (Low).

Bear Case

  • The stock is no longer early. At $100.95, shares are 10.3% above the 200-day average and only 6.5% below the 52-week and 5-year high of $107.92, which limits room for disappointment.
  • Credit costs are moving above the older normal range. FY26 ECL is guided at around 45 bps, versus the 30 to 40 bps range management outlined back in the 2024 Q3 period, and Q2 ECL was $1.1B, including $0.2B tied to Hong Kong CRE Stage 3 charges.
  • Funding quality has a caveat: management said about half of CIB deposit growth was large and short term, so not all of the $46B deposit increase should be treated as durable.
  • Cash flow optics are weak in the supplied data, with FCF $0.0B, capex $0.0B, buybacks $0.0B, and dividends $0.0B, which reduces visibility if reported accounting momentum weakens.

Valuation & Price Target

Engine price target $108.51 (+7.5% vs current), Medium confidence.

  • P/E Multiple: $117.72 (28% weight)
  • PEG (growth-adjusted): $74.55 (20% weight)
  • P/S Multiple: $99.09 (20% weight)
  • Quality-adjusted: $125.6 (20% weight)
  • DCF: $146.57 (7% weight)

The quant baseline is HOLD with a $108.51 target, but the rating leans one step more positive because the business has improved faster than a static blended multiple captures. The case for divergence is specific: Banking NII guidance is at least $46B, Q2 PBT rose 13% YoY, cost growth is held to around 1%, simplification savings were lifted to $2B, and capital remains solid at 14.1% CET1 with buybacks restarted. That said, conviction stays Medium, not High, because the stock already sits just 6.5% below its high, credit costs are guided at 45 bps, and the quant blend itself shows dispersion, from $74.55 on PEG to $146.57 on DCF. No analyst coverage is available to cross-check, and that absence is low-signal rather than supportive or negative.

Risk Assessment

Risk score 25/100 (Low). The biggest risk is that rate-driven earnings have peaked, because HSBC trades at 14.29x earnings near its highs while FY26 still assumes Banking NII of at least $46B and only around 45 bps of credit losses.

The Bottom Line

HSBC rates a BUY with Medium conviction. The stock is not a bargain-basement bank trade, but the current earnings path looks better than the market is discounting, with a raised $46B+ NII guide, tight cost control, solid capital, and resumed buybacks. The main limitation is setup: shares are already near highs, so execution has to stay clean. A downgrade to HOLD would follow if October results show NII softening, cost growth drifting above 1%, or ECL clearly moving above the guided 45 bps. Until then, the forward earnings path still supports owning the shares.

Go deeper in the app

Live charts, options analytics, the full earnings-call breakdown, price alerts, and every other stock — updated in real time.

Get Tickr